Thirty-Day Readmissions in Patients With Metastatic Cancer: Room for Improvement?

Area of Science:

• Oncology
• Health Services Research
• Public Health

Background:

• Cancer readmission rates are high, yet often excluded from reduction efforts.
• Metastatic cancer patients face unique challenges impacting readmission risk.
• Identifying avoidable readmissions is crucial for improving patient outcomes.

Purpose of the Study:

• To determine the prevalence of potentially preventable 30-day readmissions in metastatic cancer patients.
• To identify factors associated with these readmissions.
• To inform strategies for reducing readmission rates in this vulnerable population.

Main Methods:

• Utilized a merged longitudinal dataset of New York State hospital discharges and vital records (2012-2014).
• Analyzed 30-day readmissions for specific conditions (anemia, dehydration, fever, pain, etc.) in metastatic cancer patients.
• Employed competing-risk models to assess demographic, comorbidity, hospital type, payer, and discharge disposition factors.

Main Results:

• The 30-day readmission rate was 24.5%, with 11.9% deemed potentially preventable.
• Higher readmission rates were observed in Black, Hispanic, and younger patients.
• Discharge home with services and to skilled nursing facilities increased readmission likelihood, while hospice discharge and teaching hospitals were associated with lower rates.

Conclusions:

• The rate of potentially preventable readmissions in metastatic cancer patients is relatively low.
• Discharge home with services may indicate insufficient support, contributing to higher readmission rates.
• Targeted interventions and optimized post-discharge care are needed to reduce readmissions in this group.